Russian Scientists Develop a Revolutionary Approach to Treating Alzheimer’s Disease

In a remarkable scientific breakthrough, a research team from the Institute of Biomedical Systems at St. Petersburg Polytechnic University has announced the discovery of an experimental treatment that could transform the way Alzheimer’s disease—one of the most complex and widespread neurological disorders—is managed.

This new approach does not merely target the symptoms of the disease but focuses on correcting the fundamental disruption in calcium regulation within nerve cells, a key factor behind the decline of brain functions in Alzheimer’s patients.

According to researcher Evgeny Gerasimov, the experimental compound NDC-9009 has shown promising results in animal models, helping restore neuronal balance and significantly improving cognitive and behavioral functions in affected mice, particularly in areas related to memory and learning.

At the heart of the problem lies a phenomenon known as “calcium flooding”, a condition caused by the accumulation of beta-amyloid proteins, which leads to excessive calcium influx into nerve cells. This overload exhausts neurons, disrupts their communication, and eventually causes their gradual death.

Unlike conventional treatments that block calcium channels, the Russian team has adopted a more precise strategy: stimulating the SERCA pump, which is responsible for returning excess calcium to its intracellular stores. This allows cells to cope with stress without collapsing.

Scientists believe that this innovative therapeutic strategy could pave the way for more effective and less harmful medications, opening promising prospects for easing the suffering of millions of people affected by this degenerative disease worldwide.